← Grant listing · GrantsDue Pro

BJA FY 2026 Harold Rogers Prescription Drug Monitoring Program

Bureau of Justice Assistance · O-BJA-2026-172675 · Deadline: September 23, 2026 · Advertised ceiling: $2M

Program-level history — this opportunity doesn't publish per-opportunity awards, so these numbers describe its parent program (CFDA 16.754, Harold Rogers Prescription Drug Monitoring Program), not this competition alone. Labeled that way on purpose.

Ask-amount guidance

Applicants here typically receive far less than the advertised ceiling: the program median is $1.4M against a $2M ceiling (70%). Budgets far above the median need a story; budgets far below leave money on the table.

Draw-down reality (program)

Across 27 completed awards in this program (FY2021+ sample, USAspending outlay records), grantees ultimately drew a median 100% of obligated funds. A median well under 100% means underspend or early closure is common here — worth knowing before promising a spend-down timeline.

Listing summary

This is a notice of funding opportunity (NOFO) for the BJA FY2026 Harold Rogers Prescription Drug Monitoring Program (PDMP). This opportunity seeks to enhance the capacity of regulatory and law enforcement agencies and public health officials to collect and analyze controlled substance prescription data and other scheduled chemical products through a centralized database administered by an authorized agency. PDMPs help state and local governments to detect and prevent the diversion and abuse of pharmaceutically controlled substances such as opioids and other prescription drugs. The primary fun…

Eligibility: State governments, Native American tribal governments (Federally recognized), Native American tribal organizations (other) · Categories: Law, Justice and Legal Services · official listing ↗

Sources: NIH RePORTER (opportunity-exact) and USAspending (program-level), labeled per section. GrantsDue computes summaries only; verify anything critical against the originals. Methodology.